FGF2 - fibroblast growth factor 2 Gene
生物種: Sus scrofa
遺伝子タイプ: protein coding
遺伝子ID: 397643
FGF2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001405514.1 | NP_001392443.1 | fibroblast growth factor 2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
fibroblast growth factor 2 |
|
Recombinant FGF2 Proteins
| 製品番号 | 製品名 | アクセッション番号 | 純度 |
|---|---|---|---|
| HY-P700237AF | Animal-Free FGF-2 Protein, Pig (His) | NP_001392443.1 (A2-S155) | ≥ 95%, as determined by reducing SDS-PAGE. |
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
Bioactive Molecules
(3)
| 製品番号 | 製品名 |
製品効果
|
純度 |
Phase
|
|---|---|---|---|---|
| HY-15472 | PRX-08066 | 97.46% | Phase 2 | |
| HY-177668A | Umedaptanib pegol sodium | Inhibitor | / | Phase 2 |
| HY-177668 | Umedaptanib pegol | Inhibitor | / | Phase 2 |
Pre-clinical Phase
Bioactive Molecules
(32)
| 製品番号 | 製品名 |
製品効果
|
純度 |
Rare Diseases
|
|---|---|---|---|---|
| HY-122704A | Surfen dihydrochloride | Inhibitor | 99.93% | Unkown |
| HY-D0889 | Glycylglycine | 99.90% | Unkown | |
| HY-107753 | XRP44X | Inhibitor | 98.09% | Unkown |
| HY-P1408 | Obtustatin | 99.94% | Unkown | |
| HY-107194 | NSC12 | / | Unkown | |
| HY-102071 | KIN59 | Inhibitor | 99.0% | Unkown |
| HY-172443 | Keratin sulfate | 84.2% | Unkown | |
| HY-D0889R | Glycylglycine (Standard) | 99.91% | Unkown | |
| HY-RS04896 | FGF2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-10321G | PD173074 (GMP) | Inhibitor | / | Unkown |
| HY-111289 | Tec-IN-14 | Inhibitor | / | Unkown |
| HY-116030 | JNJ-26076713 | Antagonist | / | Unkown |
| HY-118792 | AHR activator 1 | / | Unkown | |
| HY-122704 | Surfen | Inhibitor | / | Unkown |
| HY-123541 | Tec-IN-6 | Inhibitor | / | Unkown |
| HY-124827 | Tec-IN-1 | Inhibitor | / | Unkown |
| HY-15472A | PRX-08066 maleate | / | Unkown | |
| HY-161840 | Antitumor agent-176 | Inhibitor | / | Unkown |
| HY-161841 | Antitumor agent-177 | Inhibitor | / | Unkown |
| HY-175076 | Globotriaosylceramide (non-hydroxy) (porcine RBC) | / | Unkown | |
| HY-P10301 | CXCL9(74-103) | / | Unkown | |
| HY-P10870 | Pep1-DNP conjugate 9 | / | Unkown | |
| HY-P3335 | SU015 | Antagonist | / | Unkown |
| HY-RS04890 | FGF13 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-118184 | AF3485 | Inhibitor | / | Unkown |
| HY-123453 | SM27 | Inhibitor | / | Unkown |
| HY-138257A | (R)-Indeloxazine benzenesulfonate | Inhibitor | / | Unkown |
| HY-165603 | Si5-N14 | Inhibitor | / | Unkown |
| HY-174702 | Human FGF2 mRNA | / | Unkown | |
| HY-RS16510 | Fgf2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22942 | Fgf2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W040074 | Glycylglycine hydrochloride hydrate | / | Unkown |
阻害性抗体
(3)
| 製品番号 | 製品名 |
製品効果
|
純度 |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991584 | HuGAL-FR21 | Inhibitor | 97.80% | Unkown |
| HY-P992201 | Anti-CD160 Antibody (MAT 302) | / | Unkown | |
| HY-P990597 | HuGAL-F2 | Inhibitor | 98.30% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service